Radiation Oncology/Therapy: Page 316

Varian installs RapidArc in NJ
By AuntMinnie.com staff writers
Radiation therapy developer Varian Medical Systems has installed its RapidArc radiotherapy technology at the Trinitas Comprehensive Cancer Center in Elizabeth, NJ.
January 13, 2009
Magliocco named RTOG pathology chair
By AuntMinnie.com staff writers
The American College of Radiology (ACR) has named Dr. Anthony Magliocco as pathology committee chair for its Radiation Therapy Oncology Group (RTOG).
January 12, 2009
Varian to post solid Q1
By AuntMinnie.com staff writers
Radiation therapy developer Varian Medical Systems said it expects to report net order growth of 12% to 13% in its fiscal 2009 first quarter, thanks to gains in all of its major businesses.
January 12, 2009
Elekta brings Compact to China
By AuntMinnie.com staff writers
Swedish oncology firm Elekta has received approval from China's State Food and Drug Administration for its Elekta Compact linear accelerator.
January 11, 2009
Bionix debuts MR-compatible headboard
By AuntMinnie.com staff writers
Radiation therapy accessories provider Bionix Radiation Therapy has released an MRI-compatible headboard.
January 7, 2009
ASTRO changes its name
By AuntMinnie.com staff writers
The American Society for Therapeutic Radiology and Oncology (ASTRO) has changed its name to the American Society for Radiation Oncology.
January 7, 2009
CMS proposes expansion of PET cancer coverage
By Wayne Forrest
The U.S. Centers for Medicare and Medicaid Services (CMS) has taken another step toward the possible expansion of Medicare coverage for initial diagnostic testing with PET for cancer patients.
January 6, 2009
Stereotactic radiosurgery adequate for treating brain metastases
By Cynthia E. Keen
U.S. researchers have found that adding whole-brain radiation therapy to stereotactic radiosurgery isn't necessary for treating patients with brain metastases. In fact, adding whole-brain radiation more than doubles a patient's risk of cognitive decline compared to those who receive only stereotactic radiosurgery.
January 6, 2009
2009 01 06 15 31 30 700 Slide21 Figure
Internal mammary node biopsies needed for better RT planning
By Cynthia E. Keen
A large study of breast cancer patients reveals that only 5% of patients with cancer-positive internal mammary nodes who receive radiation therapy (RT) will die of breast cancer recurrence within five years. This survival rate is comparable to patients with positive axillary lymph nodes who receive radiation therapy.
December 30, 2008
Radiation oncology lawsuit; a year-end thank you
By Brian Casey
December 29, 2008
Lawsuit hits Canadian cancer center for radiation therapy errors
By Cynthia E. Keen
A Canadian cancer center has been hit with a class action lawsuit claiming that hundreds of patients received improper levels of radiation during radiation therapy treatments over a three-year period.
December 29, 2008
Pediatric Hodgkin's survivors face high risk of breast cancer as young adults
By Cynthia E. Keen
Girls who received treatment for Hodgkin's disease between 1960 and 1990 and are now adult women have a 37-fold increased risk of developing breast cancer compared to the general population. The U.S. study also found that these patients had a high likelihood of developing bilateral breast cancer at an early age.
December 29, 2008
Previous Page
Page 316 of 468
Next Page